Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 10/07/2025
In
Objective
To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
AIC sector
Management group
Company website
Launch date
29/10/2019
December
Domicile
Guernsey
Fund manager
Naveen Yalamanchi, Roderick Wong, Woody Stileman, Oliver Kenyon
Dividend frequency
Data Not Available
Wind-up provisions
The Company has an unlimited life.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 409.28 | 561.11 | 1.24 | 1.70 | -27.06 | 0 | 0.00 | N/A | 1.75 (31/12/2024) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| RTW Biotech Opportunities | Share price total return | -16.8 | 12.7 | -17.3 | N/A |
| Biotechnology & Healthcare AIC sector | Share price total return | -14.6 | -15.8 | -26.6 | 37.5 |
Scroll
Share structure
Number of shares
330,063,649
15,903,791
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 299,035 | 9,634,684 | 78,141,715 | 261,285,183 |
| Average | N/A | 437,940 | 308,861 | 207,205 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.37 | 11.50 | 108.35 | 370.67 |
| Average | N/A | 0.52 | 0.43 | 0.29 |
Scroll
Trading details
Top holdings
Data as at : 31/12/2024
| Investment | % of total assets |
|---|---|
| HealthCare Inc Shs Stock Settlement | 34.2 |
| Others | 27.6 |
| Derivative Contracts, At Fair Value | 17.4 |
| Madrigal Pharmaceuticals Inc | 10.5 |
| Cortex Pharmaceuticals, Inc. | 8.5 |
| Akebia Therapeutics Inc | 5.2 |
| Rocket Pharmaceuticals Inc | 4.8 |
| Tarsus Pharmaceuticals Inc Ordinary Shares | 3.5 |
| Avidity Biosciences Inc Ordinary Shares | 1.7 |
| Securities Sold Short, At Fair Value | -15.0 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
